Literature DB >> 15319317

Internal control DNA for PCR assays introduced into lambda phage particles exhibits nuclease resistance.

Markus Stöcher1, Jörg Berg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15319317     DOI： 10.1373/clinchem.2004.035519

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  12 in total

1.  Implementation of a T4 extraction control for molecular assays of cerebrospinal fluid and stool specimens.

Authors:  Jill E Gerriets; Timothy C Greiner; Catherine L Gebhart
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

Review 2.  Design of virus-based nanomaterials for medicine, biotechnology, and energy.

Authors:  Amy M Wen; Nicole F Steinmetz
Journal:  Chem Soc Rev       Date:  2016-07-25       Impact factor: 54.564

3.  Preparation of His-tagged armored RNA phage particles as a control for real-time reverse transcription-PCR detection of severe acute respiratory syndrome coronavirus.

Authors:  Yangjian Cheng; Jianjun Niu; Yongyou Zhang; Jianwei Huang; Qingge Li
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

4.  Nuclease-resistant double-stranded DNA controls or standards for hepatitis B virus nucleic acid amplification assays.

Authors:  Shuang Meng; Sien Zhan; Jinming Li
Journal:  Virol J       Date:  2009-12-22       Impact factor: 4.099

5.  Nuclease-resistant single-stranded DNA controls for nucleic acid amplification assays.

Authors:  Antje Gotsch; Andreas Schubert; Armin Bombis; Michael Wiedmann; Michael Zauke; Stefan Schorling
Journal:  J Clin Microbiol       Date:  2007-06-06       Impact factor: 5.948

6.  Development of a new duplex real-time polymerase chain reaction assay for hepatitis B viral DNA detection.

Authors:  Shipeng Sun; Shuang Meng; Rui Zhang; Kuo Zhang; Lunan Wang; Jinming Li
Journal:  Virol J       Date:  2011-05-14       Impact factor: 4.099

7.  Improved internal control for molecular diagnosis assays.

Authors:  T Vinayagamoorthy; Danielle Maryanski; Dilanthi Vinayagamoorthy; Katie S L Hay; Jacob Yo; Mark Carter; Joseph Wiegel
Journal:  MethodsX       Date:  2015-03-12

8.  Phase I study with ONCOS-102 for the treatment of solid tumors - an evaluation of clinical response and exploratory analyses of immune markers.

Authors:  Tuuli Ranki; Sari Pesonen; Akseli Hemminki; Kaarina Partanen; Kalevi Kairemo; Tuomo Alanko; Johan Lundin; Nina Linder; Riku Turkki; Ari Ristimäki; Elke Jäger; Julia Karbach; Claudia Wahle; Matti Kankainen; Charlotta Backman; Mikael von Euler; Elina Haavisto; Tiina Hakonen; Raita Heiskanen; Magnus Jaderberg; Juuso Juhila; Petri Priha; Laura Suoranta; Lotta Vassilev; Antti Vuolanto; Timo Joensuu
Journal:  J Immunother Cancer       Date:  2016-03-15       Impact factor: 13.751

9.  XtracTB Assay, a Mycobacterium tuberculosis molecular screening test with sensitivity approaching culture.

Authors:  Jennifer L Reed; Debby Basu; Matthew A Butzler; Sally M McFall
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

10.  Internal control for real-time polymerase chain reaction based on MS2 bacteriophage for RNA viruses diagnostics.

Authors:  Miriam Ribas Zambenedetti; Daniela Parada Pavoni; Andreia Cristine Dallabona; Alejandro Correa Dominguez; Celina de Oliveira Poersch; Stenio Perdigão Fragoso; Marco Aurélio Krieger
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-04-06       Impact factor: 2.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.